Cargando…
Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767873/ https://www.ncbi.nlm.nih.gov/pubmed/35198160 http://dx.doi.org/10.1093/ckj/sfab234 |
| _version_ | 1784634810446118912 |
|---|---|
| author | Tanaka, Fumika Katayama, Kan Joh, Kensuke Tsujimoto, Kayo Yamawaki, Masahiro Saiki, Ryosuke Kurita, Tairo Murata, Tomohiro Dohi, Kaoru |
| author_facet | Tanaka, Fumika Katayama, Kan Joh, Kensuke Tsujimoto, Kayo Yamawaki, Masahiro Saiki, Ryosuke Kurita, Tairo Murata, Tomohiro Dohi, Kaoru |
| author_sort | Tanaka, Fumika |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8767873 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87678732022-01-20 Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine Tanaka, Fumika Katayama, Kan Joh, Kensuke Tsujimoto, Kayo Yamawaki, Masahiro Saiki, Ryosuke Kurita, Tairo Murata, Tomohiro Dohi, Kaoru Clin Kidney J Letter to the Editor Oxford University Press 2021-11-22 /pmc/articles/PMC8767873/ /pubmed/35198160 http://dx.doi.org/10.1093/ckj/sfab234 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letter to the Editor Tanaka, Fumika Katayama, Kan Joh, Kensuke Tsujimoto, Kayo Yamawaki, Masahiro Saiki, Ryosuke Kurita, Tairo Murata, Tomohiro Dohi, Kaoru Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine |
| title | Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine |
| title_full | Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine |
| title_fullStr | Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine |
| title_full_unstemmed | Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine |
| title_short | Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine |
| title_sort | minimal change disease with thrombotic microangiopathy following the pfizer-biontech covid-19 vaccine |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767873/ https://www.ncbi.nlm.nih.gov/pubmed/35198160 http://dx.doi.org/10.1093/ckj/sfab234 |
| work_keys_str_mv | AT tanakafumika minimalchangediseasewiththromboticmicroangiopathyfollowingthepfizerbiontechcovid19vaccine AT katayamakan minimalchangediseasewiththromboticmicroangiopathyfollowingthepfizerbiontechcovid19vaccine AT johkensuke minimalchangediseasewiththromboticmicroangiopathyfollowingthepfizerbiontechcovid19vaccine AT tsujimotokayo minimalchangediseasewiththromboticmicroangiopathyfollowingthepfizerbiontechcovid19vaccine AT yamawakimasahiro minimalchangediseasewiththromboticmicroangiopathyfollowingthepfizerbiontechcovid19vaccine AT saikiryosuke minimalchangediseasewiththromboticmicroangiopathyfollowingthepfizerbiontechcovid19vaccine AT kuritatairo minimalchangediseasewiththromboticmicroangiopathyfollowingthepfizerbiontechcovid19vaccine AT muratatomohiro minimalchangediseasewiththromboticmicroangiopathyfollowingthepfizerbiontechcovid19vaccine AT dohikaoru minimalchangediseasewiththromboticmicroangiopathyfollowingthepfizerbiontechcovid19vaccine |